PFE PFIZER INC

NYSE pfizer.com


$ 24.47 $ 0.00 (0 %)    

Tuesday, 04-Nov-2025 08:48:35 EST
QQQ $ 622.33 $ 0.00 (0 %)
DIA $ 470.43 $ 0.00 (0 %)
SPY $ 675.70 $ 0.00 (0 %)
TLT $ 89.77 $ 0.00 (0 %)
GLD $ 365.97 $ 0.00 (0 %)
$ 24.66
$ 24.53
$ 24.47 x 375
$ 24.48 x 50
-- - --
$ 20.18 - $ 27.69
140,871,289
na
140.21B
$ 0.50
$ 13.04
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-28-2025 10-Q
2 08-05-2025 06-29-2025 10-Q
3 05-05-2025 03-30-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-04-2024 09-29-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 11-08-2023 10-01-2023 10-Q
10 08-09-2023 07-02-2023 10-Q
11 05-10-2023 04-02-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-09-2022 10-02-2022 10-Q
14 08-10-2022 07-03-2022 10-Q
15 05-11-2022 04-03-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-12-2021 10-03-2021 10-Q
18 08-12-2021 07-04-2021 10-Q
19 05-13-2021 04-04-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-27-2020 10-Q
22 08-06-2020 06-28-2020 10-Q
23 05-07-2020 03-29-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-07-2019 09-29-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 07-01-2018 10-Q
31 05-10-2018 04-01-2018 10-Q
32 02-22-2018 12-31-2017 10-K
33 11-09-2017 10-01-2017 10-Q
34 08-10-2017 07-02-2017 10-Q
35 05-11-2017 04-02-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-10-2016 10-02-2016 10-Q
38 08-11-2016 07-03-2016 10-Q
39 05-12-2016 04-03-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pfizer-raises-fy2025-adj-eps-guidance-from-290-310-to-300-315-vs-304-est-affirms-fy2025-sales-guidance-of-61000b-64000b-vs-62879b-est

Pfizer (NYSE:PFE) raises FY2025 Adj EPS guidance from $2.90-$3.10 to $3.00-$3.15 vs $3.04 analyst estimate. Affirms FY2025 sale...

 pfizer-q3-adj-eps-087-beats-063-estimate-sales-16654b-beat-16592b-estimate

Pfizer (NYSE:PFE) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.63 by 38.31 pe...

 uber-amd-and-3-stocks-to-watch-heading-into-tuesday

Stock futures trading lower, watch Uber, Upwork, AMD, Starbucks, Pfizer earnings. Starbucks forms China JV. Cramer advises agai...

 michael-burry-is-super-bearish-on-palantir--with-5-million-puts

Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, am...

Core News & Articles

 - Reuters Citing Court Filing

Core News & Articles

- Reuters

Core News & Articles

- Reuters

 biontech-sees-higher-2025-sales-driven-by-bristol-myers-partnership

BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost...

 pfizer-accuses-novo-nordisk-of-antitrust-violations-in-metsera-takeover-battle

Pfizer sues Metsera and Novo Nordisk, alleging breach of contract and antitrust violations over a rival $9 billion bid challeng...

 top-stocks-with-earnings-this-week-joby-ionq-amd-and-more

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...

 how-to-earn-500-a-month-from-pfizer-stock-ahead-of-q3-earnings

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

Core News & Articles

Pfizer Inc. today announced that it has filed a second lawsuit against Metsera, Inc., its controlling stockholders, and Novo No...

Core News & Articles

-Reuters

Core News & Articles

Pfizer Inc. today announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. i...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION